S
6955
vs
EXAS
S
6955
EXAS
Over the past 12 months, Shandong Boan Biotechnology Co Ltd has underperformed EXAS, delivering a return of -30% compared to the EXAS's +4 046% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
6955
EXAS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
S
Intrinsic Value
11.73
HKD
Undervaluation 45%
EXAS
Intrinsic Value
46.13
USD
Overvaluation 98%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
6.42
HKD
|
|||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
1 865.09
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
6955, EXAS
6955, EXAS
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Shandong Boan Biotechnology Co Ltd
Revenue
|
|||||||||||
|
|
Exact Sciences Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6955, EXAS
6955, EXAS
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
|||||||||
|
|
Exact Sciences Corp
NASDAQ:EXAS
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Shandong Boan Biotechnology Co Ltd
71.7%
EXAS
69.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
Operating Margin
Shandong Boan Biotechnology Co Ltd
9.5%
EXAS
-6.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
Net Margin
Shandong Boan Biotechnology Co Ltd
4.2%
EXAS
-6.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
FCF Margin
Shandong Boan Biotechnology Co Ltd
-24.5%
EXAS
8.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
ROE
Shandong Boan Biotechnology Co Ltd
1.9%
EXAS
-8.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
ROA
Shandong Boan Biotechnology Co Ltd
1.1%
EXAS
-3.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
ROIC
Shandong Boan Biotechnology Co Ltd
3%
EXAS
-4.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
ROCE
Shandong Boan Biotechnology Co Ltd
3.2%
EXAS
-3.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Boan Biotechnology Co Ltd | ||||
|
|
Exact Sciences Corp | ||||
Solvency Comparison
S
Shandong Boan Biotechnology Co L...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
6955, EXAS
6955, EXAS
Performance By Year
6955, EXAS
6955, EXAS
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 6955 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Shandong Boan Biotechnology Co...
ABBV
Abbvie Inc
More expensive
vs Shandong Boan Biotechnology Co...
AMGN
Amgen Inc
More expensive
vs Shandong Boan Biotechnology Co...
GILD
Gilead Sciences Inc
More expensive
vs Shandong Boan Biotechnology Co...
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
